Target intelligence / Profile preview

Ganglionic nicotinic acetylcholine receptor (gAChR) (gAChR)

Target
gAChR
Molecular classification
Ion channel, Receptor, Ligand-gated ion channel
01

Overview

The ganglionic nicotinic acetylcholine receptor (gAChR) is a pentameric ligand-gated ion channel that serves as the primary mediator of fast synaptic transmission within the autonomic nervous system (PubMed ID: 18567861, 11005892). These receptors are situated on the postsynaptic membranes of neurons in sympathetic, parasympathetic, and enteric ganglia and are predominantly composed of alpha-3 and beta-4 subunits (PubMed ID: 17405096). Upon binding of acetylcholine released from preganglionic fibers, the gAChR opens to allow an influx of cations, leading to neuronal depolarization and the propagation of autonomic signals that regulate heart rate, vascular tone, and visceral motility (PubMed ID: 18567861). In the disease state of autoimmune autonomic ganglionopathy (AAG), the receptor is targeted by pathogenic autoantibodies, causing comprehensive autonomic failure (PubMed ID: 11005892). While ganglionic blockers like hexamethonium and mecamylamine were historically the first effective treatments for hypertension, their non-selective blockade of both autonomic branches causes significant side effects, such as orthostatic hypotension and dry mouth, which has largely restricted their modern clinical application (Wikipedia: Ganglionic blocker).

Other names
Autonomic nicotinic acetylcholine receptorNeuronal nicotinic acetylcholine receptor subunit alpha-3Alpha-3-beta-4 nicotinic receptorNN receptorN2 receptorAutonomic ganglion-type nicotinic receptor
02

Mechanism of action

Binding to the ganglionic nicotinic acetylcholine receptor to either antagonize (blockade) or agonize (stimulate) fast synaptic transmission between pre- and postganglionic autonomic neurons.

03

Biological functions

Signal transductionAutonomic neurotransmissionSynaptic transmissionRegulation of heart rateRegulation of blood pressureGastrointestinal motility
04

Disease associations

Autoimmune autonomic ganglionopathyAutonomic failureHypertensionOrthostatic hypotensionSmoking cessation
05

Safety considerations

Severe orthostatic hypotensionParalytic ileusUrinary retentionXerostomia (dry mouth)Cycloplegia and blurred visionSexual dysfunctionAnhidrosis
06

Interacting drugs

Hexamethonium

7 more in the full profile.

07

Biomarkers

Anti-ganglionic AChR antibodyPlasma norepinephrine levelsSympathetic skin responseQuantitative Sudomotor Axon Reflex Test (QSART)

Beyond the preview

Go deeper on Ganglionic nicotinic acetylcholine receptor (gAChR) (gAChR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ganglionic nicotinic acetylcholine receptor (gAChR) (gAChR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call